Oraya Therapeutics logo

Oraya Therapeutics

Oraya Therapeutics is a biotechnology company developing non-invasive therapies for eye diseases that is headquartered in San Francisco, California and was founded in 2007 by Michael Gertner.

3

Funding Rounds

$64.0m

Money raised

Overview

Oraya Therapeutics is a biotechnology company developing non-invasive therapies for eye diseases that is headquartered in San Francisco, California and was founded in 2007 by Michael Gertner.

Funding

Funding series

Funding Series Analysis

The company Oraya Therapeutics has raised a total of $64m in funding over 3 rounds.

Key Insights:

  • Oraya Therapeutics Series C round: $42m
  • Oraya Therapeutics Series B round: $18m
  • Oraya Therapeutics Series A round: $4m
Oraya Therapeutics logo
Oraya Therapeutics Series C round $42m
Oraya Therapeutics logo
Oraya Therapeutics Series B round $18m
Oraya Therapeutics logo
Oraya Therapeutics Series A round $4m

Industries

Oraya Therapeutics is active in the following industries: